CDKN2A and neoplasm: Furthermore, our earlier genomic and functional studies have indicated that several specific genetic alterations (such as inactivation of CDNK2A/p16 and tumor suppressors at chromosome 3p) in the premalignant nasopharyngeal epithelium support a cellular switch to state that maintains persistent latent EBV infection and predisposes individuals to NPC transformation (21–23).